Innovation and Peripheral Arterial Disease

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

DAIC

NOVEMBER 8, 2024

THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter that integrates two critical PAD treatments into a single device. The innovative feature of the Philips catheter is that both the atherectomy and lithotripsy are laser-driven. clinical trial,” said Dr.

Innovation

Innovation Peripheral Arterial Disease Technology Ultrasound

FDA Breakthrough Device Designation for Biotronik Freesolve Below-the-Knee Resorbable Magnesium Scaffold (RMS)

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. The Freesolve BTK RMS is designed for individuals suffering from chronic limb-threatening ischemia (CLTI). For more information: www.biotronik.com References: 1 Kwong M.,

Peripheral Arterial Disease

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease

Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs

DAIC

JANUARY 18, 2024

(Photo: Business Wire milla1cf Thu, 01/18/2024 - 14:05 January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for patients with below-knee peripheral arterial disease (PAD) were performed successfully using its Finesse Injectable balloon catheter platform.

Angioplasty

Angioplasty Peripheral Arterial Disease Kidney Disease Laboratory

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

DAIC

JUNE 18, 2024

However, the data with the ‘leave nothing behind’ approach with bioresorbable scaffold technologies, showed non-plateauing event rates continue to occur even after resorption of the scaffold, so we needed a more innovative approach to restore vessel viability,” said Motasim Sirhan, CEO of Elixir Medical.

Coronary Artery Disease

Coronary Artery Disease Technology Stents Stent

Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 6, 2024

Self-reported smoking status was assessed at each consecutive visit and used to determine smoking cessation after each interim ASCVD event (myocardial infarction, percutaneous coronary intervention, coronary artery bypass graft, stroke/transient ischemic attack, peripheral artery disease).

Coronary Artery Bypass Graft

Coronary Artery Bypass Graft Outpatient Peripheral Arterial Disease Cardiovascular Disease

Elixir Medical Receives FDA Breakthrough Device Designation for DynamX BTK System for Below-The-Knee Arterial Disease

DAIC

MARCH 27, 2024

Peripheral arterial disease ( PAD ) affects more than 200 million people worldwide. The Bioadaptor platform was developed to transform treatment of coronary and peripheral artery disease,” said Motasim Sirhan, CEO at Elixir Medical , based in Milpitas, CA. Glob Heart. 2014;9(1):145-158 e121.

Peripheral Arterial Disease

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease

New Dodero Center at UH will Revolutionize Limb Salvage

DAIC

FEBRUARY 14, 2025

Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.

Peripheral Arterial Disease

Peripheral Arterial Disease Cancer Innovation Best Practices

Johnson and Johnson Completes Acquisition of Shockwave Medical

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

DAIC

MAY 1, 2024

The Society for Cardiovascular Angiography & Interventions (SCAI) kicks off its SCAI Scientific Sessions 2024 this week, May 2-4 in Long Beach, CA, bringing together more than 1,800 clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine.

Interventional Cardiology

Interventional Cardiology Aortic valve TAVR Peripheral Arterial Disease

Johnson and Johnson to Acquire Shockwave Medical

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions

Cardiovascular Interventions Technology Innovation Angina

American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics

DAIC

FEBRUARY 1, 2024

The article also includes links to DAIC channels (on peripheral artery disease, stroke, heart failure, peripheral artery disease, cardiovascular clinical studies, and more) focused on specific areas of news coverage. 1 in 3 adults with Type 2 diabetes may have undetected cardiovascular disease.

Cardiovascular Disease

Cardiovascular Disease Atherosclerosis Stroke Strokes

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

DAIC

JUNE 4, 2024

a vascular surgeon and director of HonorHealth’s vascular services, said the device avoids carotid endarterectomy, a previous method for removing plaque from carotid arteries, which involves a surgical procedure requiring an incision directly into the neck. who has suffered from peripheral artery disease for years.

Stent

Stent Stents Research Stroke

One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System

DAIC

MAY 30, 2024

The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5%

Stent

Stent Stents Peripheral Arterial Disease Innovation

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

DAIC

MAY 8, 2024

The 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS).” Journal of Vascular Surgery Cases, Innovations and Techniques, vol. Journal of Vascular Surgery, Mar. 2024, [link]. 2 Halliday, Alison, and Jeroen J.

Coronary Artery Disease

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction

University Hospitals Receives Grant for New Limb Preservation Center

DAIC

FEBRUARY 14, 2025

Led by Mehdi Shishehbor DO, MPH, PhD, interventional cardiologist and a pioneer in the field of limb preservation, the Dodero Center will revolutionize care for patients at risk of losing a leg due to peripheral artery disease and diabetes.

Hospital

Hospital Peripheral Arterial Disease Cancer Innovation

Cardiovascular Update

Philips Enrolls First Patient in Clinical Trial for Integrated Single-Device to Treat PAD

FDA Breakthrough Device Designation for Biotronik Freesolve Below-the-Knee Resorbable Magnesium Scaffold (RMS)

Injectable Angioplasty Balloon Catheter Transforms Peripheral Procedures, Users Report Reduced Equipment and Contrast Needs

Webinars

Elixir Medical Granted FDA Breakthrough Device Designation for DynamX Bioadaptor

Association Between Cardiovascular Event Type and Smoking Cessation Rates Among Outpatients With Atherosclerotic Cardiovascular Disease: Insights From the NCDR PINNACLE Registry

Elixir Medical Receives FDA Breakthrough Device Designation for DynamX BTK System for Below-The-Knee Arterial Disease

New Dodero Center at UH will Revolutionize Limb Salvage

Johnson and Johnson Completes Acquisition of Shockwave Medical

Groundbreaking Data in Interventional Cardiology to be Featured at Society for Cardiovascular Angiology and Interventions SCAI 2024 Scientific Sessions

Johnson and Johnson to Acquire Shockwave Medical

American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics

HonorHealth Research Institute First in Southwest to Implant New Stroke Prevention Stent

One-Year BIONETIC-I Study Results Show Safety and Effectiveness of Iliac Artery Treatment With BIOTRONIK’s Dynetic-35 Cobalt Chromium Balloon-Expandable Stent System

HeartFlow Announces Revolutionary Five-Year Data Demonstrating a 63 Percent Mortality Reduction with FFRCT-Guided Care in PAD Patients

University Hospitals Receives Grant for New Limb Preservation Center

Stay Connected